Samsung Biologics acquires drug product manufacturing approval from U.S. FDA

Samsung Biologics(CEO Tae-Han Kim) announced on the 25^th that they acquired manufacturing approval of its first finished drug product from the Food and Drug Administration, a federal agency of the United States Department of Health and Human Services.

Previously, the company acquired product approval from the European Medicines Agency(EMA) and the Japanese Pharmaceuticals and Medical Devices A...